Return to study ST002523 main page
MB Sample ID: SA254493
Local Sample ID: | MK175 |
Subject ID: | SU002623 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 68 (63, 73) |
Weight Or Weight Range: | 77 (62, 87) |
Height Or Height Range: | 170 (160, 176) |
Gender: | Male and female |
Human Ethnicity: | White |
Human Medications: | anti-PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab) |
Human Inclusion Criteria: | consecutive advanced cancer patients |
Select appropriate tab below to view additional metadata details:
Subject:
Subject ID: | SU002623 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 68 (63, 73) |
Weight Or Weight Range: | 77 (62, 87) |
Height Or Height Range: | 170 (160, 176) |
Gender: | Male and female |
Human Ethnicity: | White |
Human Medications: | anti-PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab) |
Human Inclusion Criteria: | consecutive advanced cancer patients |